BMS-582664 in Combination With Erbitux in Patients With Advanced Gastrointestinal Malignancies

Clinical trial NCT00207051 · COMPLETED

Trial details

NCT number: NCT00207051
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Colorectal Cancer

Start date: 2006-01-01
Primary completion: 2008-12-01
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.